Blood Test for Brain Cancer May Be on Horizon

A new blood-based test to screen for biomarkers of glioblastoma brain cancer has been developed by researchers at Penn State. The test looks for elevated levels of IL13Rα2, an antigen receptor that is derived from glioblastoma tumors.

from Neuroscience News https://ift.tt/MwThpoa